C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-02 · 46 (2)
DOI: 10.1002/phar.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 25.12.2025. Verfasst von Nicoline Bihelek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lower Mainland Pharmacy Services, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Clozapine, C-Reactive Protein, Neutrophils, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Clozapine initiation often triggers inflammatory responses that can alter metabolism via Cytochrome P450 1A2 (CYP1A2) suppression. Although C‐reactive protein (CRP) is the recommended marker, it may be unavailable in community settings. Neutrophil‐to‐lymphocyte ratio (NLR), routinely measured, could serve as a surrogate, though its value in detecting clozapine‐related inflammation and metabolic changes remains unclear.
Aims
This study aimed to assess the relationship between CRP and NLR in individuals treated with clozapine, evaluate whether NLR can act as a proxy for elevated CRP (> 5 mg/L), and determine whether NLR, like CRP, explains variability in clozapine metabolism (concentration to dose (C/D) ratios) after adjusting for covariates.
Methods
We performed a retrospective cohort study of clozapine‐treated inpatients at the British Columbia Psychosis Program (2012–2021). Patients with clozapine levels and matched complete blood counts (CBCs) (±7 days) were included, with CRP added when available. Multivariate mixed models assessed associations between CRP, NLR, and clozapine C/D ratios, while receiver operating characteristic (ROC) analyses evaluated NLR as a proxy for elevated CRP.
Results
Among 150 patients, 760 clozapine serum/CBC pairs and 212 CRP measurements met eligibility criteria. NLR was modestly associated with CRP (estimate = 0.027, p < 0.001). ROC analysis indicated that NLR had limited predictive utility, with an area under the curve (AUC) of 0.640 for detecting CRP > 5 mg/L. Subsequent analyses for higher CRP thresholds (> 10 and > 20 mg/L) produced comparable NLR AUC values of 0.621 and 0.669, respectively. Neutrophil count alone demonstrated marginally better performance but remained similarly limited in predictive value. In multivariate models, CRP but not NLR, was independently associated with clozapine C/D ratios.
Conclusion
Our findings indicate that although NLR and other hematological indices are easily accessible and may provide some indication of inflammation, they cannot substitute for CRP in guiding clozapine titration decisions. Where CRP is unavailable, NLR > 3 may be cautiously informative, though CRP remains the preferred marker for early detection and dose adjustment to optimize tolerability, adherence, and safety during clozapine initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lower Mainland Pharmacy Services, Vancouver, British Columbia, Canada.
- Departments of Psychiatry, Medical Genetics, Physiology & Pharmacology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
- Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
- BC Psychosis Program, UBC Hospital, Vancouver, British Columbia, Canada.
ORCID-Profile: Chad A Bousman, Reza Rafizadeh
Zitieren
APA
Bihelek, N., Bousman, C. A., Honer, W. G., & Rafizadeh, R. (2026). C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(2). https://doi.org/10.1002/phar.70094
Vancouver
Bihelek N, Bousman CA, Honer WG, Rafizadeh R. C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(2). doi:10.1002/phar.70094
BibTeX
@article{Bihelek2026,
author = {Bihelek, Nicoline and Bousman, Chad A and Honer, William G and Rafizadeh, Reza},
title = {C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2026},
volume = {46},
number = {2},
doi = {10.1002/phar.70094}
}
EUVIMED